We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Mergers and Acquisitions

News List

Growth-hungry Gilead acquires Kite at $12B for its nearly approved CAR-T treatment expressbpd
August 29, 2017
Gilead Sciences will buy Kite Pharma for nearly $12 billion, when Kite's cutting-edge CAR-T treatment is nearly approved.
Deals of Biotech down by half possibly making it the lowest since 2013 fiercebiotech
August 21, 2017
Valuations are too high in biotech, that's what Big Pharma CEOs have stated in their last few quarterly financials again and again.
China's Fosun, Shanghai Pharma circle Georgia drugmaker Arbor for U.S. beef-up fiercepharma
August 15, 2017
Fosun and Shanghai Pharma are bidding for a stake in U.S. drugmaker Arbor Pharma, as the Chinese banking authorities crack down on debt-fueled foreign acquisitions.
Trends in pharmaceutical mergers and acquisitions biopharmadealmakers.nature
February 20, 2017
The number of mergers and acquisitions in the pharmaceutical industry has continued to rise, with oncology being a particularly active area and assets increasingly being acquired at earlier stages of their development.

Previous page 1 2 Next page